FDA Panel Backs Use Of Actelion Ltd.'s (JOBS) Zavesca For Rare Genetic Disorder

Reuters -- A U.S. advisory panel on Tuesday recommended approval of an Actelion Ltd drug for treating a rare disease that often kills patients in their teens after fats accumulate in their organs.